Get Updates
Get notified of breaking news, exclusive insights, and must-see stories!

Dabur Pharma inks agreement with Thai firm

New Delhi, Apr 9 (UNI) Dabur Pharma today said it has signed an agreement with Thailand-based Government Pharmaceutical Organization (GPO) for generic version of one of its key anti-cancer products.

''Dabur Pharma is committed to providing high quality anti-cancer products at cost effective prices. The agreement with GPO has been signed for generic Docetaxel Injection at a very special price,'' Dabur Pharma CEO Ajay Kumar Vij said in a statement.

GPO will be importing the product in Thailand and then making it available to needy patients, he added.

UNI SBA SG GC1726

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+